Evidence map›Paper›PMID 41674563›Full record

ArticleiMetaOmics2025

Wei Lyu, Lu Chen, De-Feng Li, Shu-Ying Li, Qian Dai, Hong-Li Zhou, Yan-Yan Liu, Jian-Yun Zhou, Xin-Jun Liang, Ling Wang

Abstract read
In one paragraph

Article in iMetaOmics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei LyuClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Lu ChenInstitute of Food and Nutrition Development Ministry of Agriculture and Rural Affairs Beijing China.
De-Feng LiClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Shu-Ying LiClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Qian DaiClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Hong-Li ZhouClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Yan-Yan LiuDepartment of Nephrology, Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Jian-Yun ZhouClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.
Xin-Jun LiangDepartment of Medical Oncology, Hubei Cancer Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Ling WangClinical Medical Research Center The Second Affiliated Hospital of Army Military Medical University Chongqing China.ORCID https://orcid.org/0000-0001-9292-8989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During colorectal cancer (CRC) progression, probiotics support gut microbial balance, enhance intestinal barrier integrity, and exert antioxidant and anti-inflammatory effects. Such supplementation may slow tumor growth and serve as an adjunctive therapy for CRC. In this study, we evaluated the impact of

Indexed as

colorectal cancergut microbiotaLactobacillus johnsonii‐FM1vanillic acid

Identifiers

PMID41674563
PMCPMC12806084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.